QIM
RGLS

Quantitative Investment Management’s Regulus Therapeutics RGLS Stock Holding History

Quantitative Investment Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-382
Closed -$47K – 893
2017
Q4 		$47K Sell
382
-1,101
-74% -$139K ﹤0.01% 734
2017
Q3 		$222K Buy
1,483
+608
+69% +$76.5K ﹤0.01% 651
2017
Q2 		$103K Buy
+875
New +$146K ﹤0.01% 663
2015
Q4 		– Sell
-141
Closed -$110K – 819
2015
Q3 		$110K Buy
141
+17
+14% +$17.4K 0.01% 636
2015
Q2 		$163K Buy
+124
New +$200K 0.02% 400

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Quantitative Investment Management's RGLS Position: Q1 2018 in Review

Quantitative Investment Management sold out of Regulus Therapeutics (RGLS) in Q1 2018, closing a stake of 382 shares — an estimated $47K sold.

Quantitative Investment Management first reported a position in RGLS in Q2 2015 and held it in 5 quarters. The position peaked at $222K in Q3 2017. 50 funds tracked by Wall St. Rank hold RGLS as of Q1 2018.

  • Quantitative Investment Management reported no remaining Regulus Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 382 Regulus Therapeutics shares in Q1 2018, an estimated $47K.
  • Quantitative Investment Management first reported a position in Regulus Therapeutics in Q2 2015 and held it in 5 quarters.
  • Quantitative Investment Management's Regulus Therapeutics position peaked at $222K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2018.

Based on Quantitative Investment Management's 13F filing for Q1 2018, filed 15 May 2018.